Home Blog Page 99

Blog

Pharma Marketing Blog

Most popular

“Sixty Minutes” — Sponsored by Sanofi — Exposes the “Financial Toxicity”...

Pharma Guy - October 6, 2014

My Bad! Paula Dean Shills for Novo Nordisk, Not Novartis

Pharma Guy - January 17, 2012

The “One-Click Rule”: Rant or No Rant?

Pharma Guy - November 14, 2007

Pay Per DTC Ad View Update

Pharma Guy - November 21, 2006

Is “Right to Try” a Good Idea?

Pharma Guy - March 1, 2017

Disease Mongering and Pharma Credibility

Pharma Guy - January 25, 2007

A New Era of Pharma Marketing: Direct to Journalist (DTJ)

Pharma Guy - July 15, 2009

Thanks to My Twitter Pals I Donate $50 to Nothing But...

Pharma Guy - April 21, 2009

Jarvik Falters in His Own Defense

Pharma Guy - January 24, 2008

The Drug Industry Needs Constructive Criticism, Not Pugilistic Put Downs

Pharma Guy - June 21, 2007

1...9899100...240 Page 99 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026